2009 Annual Meeting | Interventional Therapy for Acute Ischemic Stroke

Date Friday 05/01/09

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Tudor G. Jovin, MD

Topic(s)

Learning Objectives Participants should be familiar with the selection paradigms in acute stroke, including the most recent advances in imaging modalities, and be exposed to the currently employed forms of endovascular treatment.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:45 AM - 07:05 AM		Patient Selection for Intra-Arterial Therapy in Acute Stroke Caused by Large Vessel Occlusion Tudor G. Jovin, MD
06:45 AM - 08:30 AM		Breakfast
07:05 AM - 07:25 AM		Pharmacologic Endovascular Treatment of Acute Ischemic Stroke Rishi Gupta, MD
07:25 AM - 07:45 AM		Mechanical Recanalization Strategies in Acute Ischemic Stroke Caused by Large Vessel Occlusion Raul G. Nogueira, MD
07:45 AM - 08:30 AM		Case Presentation Interactive Session

Faculty Disclosures
Tudor G. Jovin, MD	Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.
Raul G. Nogueira, MD	Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.
Rishi Gupta, MD	No disclosure on file

��ɫ��

��ɫ��